Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 904-155-3 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The acute oral toxicity of the Reaction mass of 2,2'-[methylenebis(oxymethylene)]bis[2-ethylpropane-1,3-diol] and 2,2'-[oxybis(methylene)]bis[2-ethylpropane-1,3-diol] and propylidynetrimethanol is low. The oral LD50 of the substance was determined to be > 2000 mg/kg bw in an acute oral toxicity study conducted in rats using the Acute Toxic Class Method according to OECD Test Guideline 423 (Robertson, 2012). A waiver is proposed for acute dermal toxicity on scientific grounds and for reasons of animal welfare: low acute dermal toxicity is predicted based on available information. A waiver is proposed in accordance with Column 2 of Annex VIII of the REACH Regulation for acute inhalation toxicity on the basis that acute toxicity data are available for the oral route and acute dermal toxicity is similarly predicted to be low. Inhalation is not predicted to be a significant route of exposure based on the physicochemical properties of the substance.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23rd May 2012 to 9th August 2012.
- Reliability:
- 1 (reliable without restriction)
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- not specified
- Principles of method if other than guideline:
- Not applicable.
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River UK Limited, Manston Road, Margate, Kent, UK
- Age at study initiation: 8 to 11 weeks old.
- Weight at study initiation: 226.1 to 244.2g.
- Fasting period before study: Animals were fasted overnight prior to dosing.
- Housing: Animals were housed in groups of 3 in appropriately sized solid-bottomed polycarbonate cages with stainless steel mesh tops. Cages were suspended on movable racks and wood shavings were used as bedding.
- Diet (e.g. ad libitum): SDS Rat and Mouse (modified) No. 1 Diet SQC Expanded was provided ad libitum throughout the study.
- Water (e.g. ad libitum): Water from public supply was provided ad libitum.
- Acclimation period: At least 9 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): The environmental daily average temperature was approximately 20°C.
- Humidity (%): The range of daily average relative humidity was approximately 45% to 57%.
- Air changes (per hr): Minimum of 10 air changes per hour.
- Photoperiod (hrs dark / hrs light): 12 h light/dark cycle
IN-LIFE DATES: From: To: - Route of administration:
- oral: gavage
- Vehicle:
- other: Milli-Q water
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 10mL/kg.
DOSAGE PREPARATION (if unusual):
Formulations were prepared on each day of dosing. The test item was placed in a sealed bag and immersed in a water bath that was set to a maximum temperature of 80°C until it was visibly homogeneous. The required amount of HB TMP was weighed into a pre-labelled container and formulations were made up to the final volume by adding the requisite amount of Milli-Q water. Formulations were stirred using a magnetic stirrer.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: 300 mg/kg was selected as a suitable starting dose level for administration to Group 1 animals, as recommended in OECD Guideline No. 423. There were no adverse signs recorded in any animal. In order to minimise the number of animals used, the repeat administration of the 300 mg/kg dose level to Group 2 animals was not performed and instead selected a dose level of 2000 mg/kg from the 4 fixed dose levels presented in the OECD Guideline. There were no signs of systemic toxicity in these animals either and so a third group of rats was treated at the same dose level to complete the study. - Doses:
- 300 and 2000 mg/kg.
- No. of animals per sex per dose:
- 3 females per dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Prior to dosing on day 1 and on Days 8 and 15.
- Necropsy of survivors performed: yes. The necropsy consisted of an examination of the cranial, thoracic and abdominal organs and tissues in situ.
- Other examinations performed: clinical signs, body weight, other: mortality and moribundity. - Statistics:
- No formal statistic analysis was conducted.
- Preliminary study:
- Not applicable.
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths during the observation period.
- Clinical signs:
- other: Clinical signs were restricted to 2 animals that were treated with HB TMP at 2000 mg/kg. Animal 6 displayed a red nasal discharge predose and immediately and approximately 30 min post dose on Day 1. Staining around the muzzle of Animal 4 and Animal 6 wa
- Gross pathology:
- Necropsy on Day 15 revealed no macroscopic abnormalities in any animal.
- Other findings:
- No additional information applicable.
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study, the LD50 of HB TMP in Sprague-Dawley was not classified.
- Executive summary:
The acute oral toxicity of HB TMP was investigated in an study conducted using the Acute Toxic Class method, according to OECd Test Guideline 423. In the study, a single oral (gavage) dose of the test substance at 300, 2000 or 2000 mg/kg bw was administered to three respectie groups of female Sprague-Dawley rats. Animals were observed for 14 days after the day of dosing. All animals survived treatment. No treatment-related adverse clinical skigns and no macroscopic abnormalities were recorded in any animal. Bodyweights were considered to be acceptable for rats of this age and strain. Under the condistions of the study, the median lethal dose of HB TMP in Sprague-Dawley rats was > limit dose of 2000 mg/kg and the substance was therefore considered to be unclassofied according to the Globally Harmonised Classification System.
Reference
No additional information.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Klimisch score = 1. Study compliant with current test guidelines and GLP.
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Data waiving:
- other justification
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Data waiving:
- study scientifically not necessary / other information available
- Justification for data waiving:
- other:
Reference
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity
The acute oral toxicity of the Reaction mass of 2,2'-[methylenebis(oxymethylene)]bis[2-ethylpropane-1,3-diol] and 2,2'-[oxybis(methylene)]bis[2-ethylpropane-1,3-diol] and propylidynetrimethanol is low. The acute oral median lethal dose (LD50) of the substance was determined to be > 2000 mg/kg bw in an acute oral toxicity study conducted in rats according to OECD Test Guideline 423 (Acute Toxic Class method; Robertson, 2012).
In the study, a single oral (gavage) dose of the test substance at 300, 2000 or 2000 mg/kg bw was administered to three respective groups of female Sprague-Dawley rats. Animals were observed for 14 days after the day of dosing. All animals survived treatment. No treatment-related adverse clinical signs and no macroscopic abnormalities were recorded in any animal. Bodyweights were considered to be acceptable for rats of this age and strain. Under the conditions of the study the median lethal dose of the Reaction mass of 2,2'-[methylenebis(oxymethylene)]bis[2-ethylpropane-1,3-diol] and 2,2'-[oxybis(methylene)]bis[2-ethylpropane-1,3-diol] and propylidynetrimethanol in Sprague-Dawley rats was > the limit dose of 2000 mg/kg and the substance was therefore considered to be unclassified according to the Globally Harmonised Classification System.
Acute dermal toxicity
No acute dermal toxicity studies on the substance are available. A waiver is proposed for this endpoint on scientific grounds and for reasons of animal welfare. No adverse effects or mortalities were seen in an acute oral toxicity study performed with the substance at a limit dose of 2000 mg/kg bw. No signs of systemic toxicity were seen in a skin irritation study or in a skin sensitisation study using the substance. It can therefore be concluded that the substance has low acute toxicity. Dermal absorption of the substance is unlikely to exceed oral absorption and significant differences in the toxicity of the substance due to the route of exposure are not predicted. Testing of the substance is therefore not considered to be scientifically justified and additionally cannot be supported on grounds of animal welfare.
Acute inhalation toxicity
A waiver is proposed for acute inhalation toxicity studies in accordance with Column 2 of Annex VIII of the REACH Regulation for this endpoint on the basis that acute toxicity data are available for the oral route and acute dermal toxicity is similarly predicted to be low. Inhalation is not predicted to be a significant route of exposure based on the physicochemical properties of the substance. The substance is a non-volatile liquid and the use pattern indicates that significant inhalation exposure is unlikely. No additional testing is therefore warranted.
Justification for selection of acute toxicity – oral endpoint
Sole study providing data from a guideline compliant study.
Justification for classification or non-classification
The oral LD50of the Reaction mass of 2,2'-[methylenebis(oxymethylene)]bis[2-ethylpropane-1,3-diol] and 2,2'-[oxybis(methylene)]bis[2-ethylpropane-1,3-diol] and propylidynetrimethanol in rats is > 2000 mg/kg bw. The substance does not meet the criteria for classification for acute oral toxicity according to Directive 67/548/EEC or Regulation 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.